Crossref
Harmine and extendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system
Yearbook of Paediatric Endocrinology · 30.09.2025
DOI: 10.1530/ey.22.10.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Rosselot C und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
C, R., Y, L., P, W., A, A., K, B., G, L., & al, E. (2025). Harmine and extendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.10.15
Vancouver
C R, Y L, P W, A A, K B, G L, et al. Harmine and extendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.10.15
BibTeX
@article{C2025,
author = {C, Rosselot and Y, Li and P, Wang and A, Alvarsson and K, Beliard and G, Lu and al, et},
title = {Harmine and extendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system},
journal = {Yearbook of Paediatric Endocrinology},
year = {2025},
doi = {10.1530/ey.22.10.15}
}
EUVIMED